DMAC - DiaMedica Therapeutics GAAP EPS of -$0.12 beats by $0.03 November, 09 2022 05:22 PM DiaMedica Therapeutics Inc. DiaMedica Therapeutics press release ( NASDAQ: DMAC ): Q3 GAAP EPS of -$0.12 beats by $0.03 . Total cash, cash equivalents and investments of $36.1M. For further details see: DiaMedica Therapeutics GAAP EPS of -$0.12 beats by $0.03